Track the PFP stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on the AU market, under the authority of ASX. Operating in the Health Care sector, PFP has logged 3 public disclosures. Market capitalisation: €465m. The latest transaction was reported on 2 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is free.
Analysts rate PFP Buy (bullish), based on 6 analysts. Average price target: A$4.74.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
PFP es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XASX. Se enfoca en el desarrollo y comercialización de soluciones innovadoras para mejorar la atención médica.